Studies have shown 93% of convalescent patients possess detectable circulating CD4+ T cells specific to SARS-CoV-2 S-protein, N-protein, and M-protein29,34,35, and 50% of acute COVID-19 cases35. Here, CD4 is linked to COVID-19.